Vitamin D and COVID-19: what does the evidence establish?

Early in the pandemic, reports linked low vitamin D levels with worse health outcomes. The old version of this article treated some hypotheses as established facts and contained incorrect advice. We are restoring the address with corrections rather than perpetuating those claims. This is a discussion of evidence, not a personalised treatment plan.

No. An observational study may identify an association between deficiency and illness without showing that a supplement will prevent infection. Other factors, such as health status or age, can affect both. Observing an association and testing an intervention’s effectiveness are different tasks. This is a basic principle of interpreting data beyond medicine as well.

The randomised CORONAVIT trial, published in the BMJ in 2022, did not show a reduction in COVID-19 risk from its vitamin D testing and supplementation-offer strategy. That finding concerns a specific intervention and population; it does not mean that diagnosed deficiency should be ignored.

NICE guidance does not recommend using it to treat COVID-19 outside a clinical trial. Correcting deficiency for other indications is a separate matter. We do not present supplements or nasal sprays as replacements for recommended prevention or treatment. Discuss symptoms, testing and supplementation with a clinician, taking existing conditions and medicines into account.

A low vitamin D result alone does not diagnose cancer or autoimmune disease. Lifelong protection against another COVID-19 infection cannot be promised after recovery. Describing mRNA vaccines as altering the human genome was also incorrect. The European Vaccination Information Portal explains that they do not change DNA.

We no longer suggest that everyone should target 50–100 ng/ml or take an identical supplement combination. Excess vitamin D can be harmful. Reference ranges, reasons for testing and doses need an appropriate clinical context.

Check whether the report concerns a laboratory experiment, observations in people or a randomised trial. Look at participant numbers, the intervention, the measured outcome and uncertainty. A large percentage in a headline is not enough for a health decision. The sources below allow readers to check what was actually studied and recommended.